Notice Concerning Additional Approval In Japan For Freeze-Dried, Cell Culture-Derived Smallpox Vaccine Lc16 "Kmb" For Prevention Of Monkeypox

Meiji Holdings

03/08/2022 08:03

Aug 3 (Reuters) - Meiji Holdings Co Ltd  2269.T :
    * NOTICE CONCERNING ADDITIONAL APPROVAL IN JAPAN FOR
FREEZE-DRIED,
CELL CULTURE-DERIVED SMALLPOX VACCINE LC16 "KMB" FOR PREVENTION
OF MONKEYPOX

Source text for Eikon:  ID:nTStc7cc15 
Further company coverage:  2269.T